Yoshitaka Honma

17PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologySystems physiologyMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 29, 2026
A multicenter randomized phase III trial to evaluate the value of omission of elective neck dissection for T3-T4aN0 laryngeal cancer: JCOG2407 (JALNECK).

|Jun 24, 2026
A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

|May 20, 2026
Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil Therapy on Synchronous Early-Stage Oropharyngeal/Hypopharyngeal Cancer in Patients With Esophageal Cancer.

|May 05, 2026
Enfortumab vedotin plus pembrolizumab as first-line treatment in recurrent or metastatic head and neck squamous cell carcinoma: results from EV-202 cohort 9.

|Apr 13, 2026
Non-surgical definitive treatment and geriatric assessment in older patients with locally advanced head and neck cancer.

Koichi Yasuda, Yoshitaka Honma, Yuri Ueda

|Mar 19, 2026
Early Mycophenolate Mofetil Combination Therapy as an Effective Approach for Immune-Related Hepatitis Induced by Immune Checkpoint Inhibitors in Patients With Solid Tumor.

Yukiko Shimoda Igawa, Tatsuya Yoshida, Jun Sato

Pageof 3

Frequent Collaborators

3 joint publications

Kengo Nagashima

3 joint publications

Nobuhiro Hanai

3 joint publications

Naomi Kiyota

2 joint publications

Hirokazu Shoji